| | | |
| Join us on September 24, 2025, for a free virtual expo tailored to clinical teams evaluating IRT/RTSM platforms. Get live 15-minute demos, real-time Q&A, and side-by-side comparisons from top vendors. Ideal for Clinical Ops, Trial Supply, Data Management, and Procurement professionals, this event helps accelerate vendor selection and streamline study planning. |
|
| | | A conversation with Randy Peterson, RadioMedix | From the moment radiolabeled drugs are made, it’s a race to get them to patients. Radioactive decay is just one of many complications. Here’s one company’s approach. | |
|
| | | RTSM/IRT In Clinical Trials: The Complete Guide | Article | Signant Health | RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance. |
|
| | Risk Mitigation In Direct-To-Patient Clinical Trials | Article | By Nicole Gray, Catalent | The DTP model can help alleviate risks in patient enrollment (including diversity), retention, and adherence to study timelines and budgets. Explore how to ease trial troubles through DTP. |
|
| | | |
| Join CHI's 8th Annual SCOPE Europe in Barcelona for three days of clinical operations innovation. Explore six conferences, 50 exhibitors, and cutting-edge case studies. Network with 700+ senior executives from 300 organizations across 30 countries, including Pharma, Biotech, CROs, tech providers, and more. Attend keynotes, panels, and breakouts focused on clinical trial excellence. Don’t miss this premier event driving the future of clinical research and operations. www.SCOPEsummitEurope.com |
|
| | | | |
| Revolutionize your approach to clinical trials at DPHARM: Disruptive Innovations to Modernize Clinical Research, taking place September 16–17, 2025, in Philadelphia. This conference showcases cutting-edge strategies and technologies designed to reduce patient and site burden, streamline operations, improve data quality, and accelerate access to therapies. |
|
|
|
|